Loading...

Xvivo Perfusion AB (publ)

XVIPYPNK
Healthcare
Medical - Specialties
$7.50
$-0.20(-2.60%)

Xvivo Perfusion AB (publ) XVIPY Peers

See (XVIPY) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Specialties Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
XVIPY$7.50-2.60%945MN/AN/AN/A
BMXXY$12.95+0.00%13.5B27.19$0.42+0.90%
EBOSY$41.94+0.00%2.4B25.68$1.83+1.14%
EBRCZ$0.55+0.00%204.4M-4.57-$0.12N/A
TRXDW$0.15-11.76%40.1MN/AN/AN/A
NVNBW$0.40+33.33%7M-0.21-$1.95N/A
GWPC$0.00+0.00%52K-0.01-$0.01N/A
SXHHF$0.00-0.00%38.1K-0.01-$0.01N/A
DGCRF$0.00+0.00%21.5K0.00$0.05N/A
KKUR$0.00+0.00%8.2KN/AN/AN/A
Showing 1 to 10 of 21 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

XVIPY vs BMXXY Comparison

XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XVIPY stands at 945M. In comparison, BMXXY has a market cap of 13.5B. Regarding current trading prices, XVIPY is priced at $7.50, while BMXXY trades at $12.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XVIPY currently has a P/E ratio of N/A, whereas BMXXY's P/E ratio is 27.19. In terms of profitability, XVIPY's ROE is +0.10%, compared to BMXXY's ROE of +0.10%. Regarding short-term risk, XVIPY and BMXXY have similar daily volatility (0.00).

Stock Price Comparison

Loading...

Frequently Asked Questions

;